D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
-10.3%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$61.5B
AUM Growth
-$14.6B
Cap. Flow
-$10.1B
Cap. Flow %
-16.36%
Top 10 Hldgs %
10.78%
Holding
4,727
New
431
Increased
1,418
Reduced
1,362
Closed
552

Sector Composition

1 Technology 17.19%
2 Financials 14.3%
3 Healthcare 10.79%
4 Consumer Discretionary 9.85%
5 Industrials 7.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CRBU icon
3301
Caribou Biosciences
CRBU
$179M
$151K ﹤0.01%
27,884
-200,143
-88% -$1.08M
GORV icon
3302
Lazydays
GORV
$9.08M
$151K ﹤0.01%
+428
New +$151K
RYTM icon
3303
Rhythm Pharmaceuticals
RYTM
$6.5B
$151K ﹤0.01%
36,492
-60,493
-62% -$250K
SST.WS
3304
DELISTED
System1, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SST.WS
$151K ﹤0.01%
186,079
-13,787
-7% -$11.2K
DSKE
3305
DELISTED
Daseke, Inc. Common Stock
DSKE
$151K ﹤0.01%
23,567
+2,782
+13% +$17.8K
CMAX
3306
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$151K ﹤0.01%
+1,391
New +$151K
SRTS icon
3307
Sensus Healthcare
SRTS
$53.4M
$150K ﹤0.01%
+19,595
New +$150K
NEUE icon
3308
NeueHealth
NEUE
$61.5M
$150K ﹤0.01%
1,033
-19,324
-95% -$2.81M
SAGAR
3309
DELISTED
Sagaliam Acquisition Corp. Rights
SAGAR
$150K ﹤0.01%
990,000
+495,000
+100% +$75K
GLSI icon
3310
Greenwich LifeSciences
GLSI
$156M
$149K ﹤0.01%
+17,631
New +$149K
MERC icon
3311
Mercer International
MERC
$209M
$149K ﹤0.01%
11,347
-42,865
-79% -$563K
MCRB icon
3312
Seres Therapeutics
MCRB
$153M
$148K ﹤0.01%
2,157
-2,625
-55% -$180K
DRIO icon
3313
DarioHealth
DRIO
$17M
$147K ﹤0.01%
1,196
+653
+120% +$80.3K
HBIO icon
3314
Harvard Bioscience
HBIO
$19.7M
$146K ﹤0.01%
+40,689
New +$146K
CANO.WS
3315
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$146K ﹤0.01%
+215,000
New +$146K
ROIVW
3316
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$146K ﹤0.01%
+242,918
New +$146K
RFL icon
3317
Rafael Holdings
RFL
$47M
$145K ﹤0.01%
78,559
-19,424
-20% -$35.9K
RUMBW
3318
Rumble Inc. Warrant
RUMBW
$755M
$145K ﹤0.01%
107,072
ANNX icon
3319
Annexon
ANNX
$279M
$144K ﹤0.01%
38,326
-125,053
-77% -$470K
APYX icon
3320
Apyx Medical
APYX
$75.6M
$144K ﹤0.01%
+24,586
New +$144K
CBIO
3321
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
$144K ﹤0.01%
2,420
-137
-5% -$8.15K
CAAP icon
3322
Corporacion America
CAAP
$3.26B
$143K ﹤0.01%
25,623
+8,338
+48% +$46.5K
FPH icon
3323
Five Point Holdings
FPH
$418M
$143K ﹤0.01%
36,650
-5,828
-14% -$22.7K
GHY
3324
PGIM Global High Yield Fund
GHY
$541M
$143K ﹤0.01%
12,500
TNYA icon
3325
Tenaya Therapeutics
TNYA
$209M
$143K ﹤0.01%
25,440
-13,076
-34% -$73.5K